2006
DOI: 10.1159/000092291
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment of Nodular Actinic Reticuloid with Tacrolimus Ointment

Abstract: Actinic reticuloid (AR) is the severest clinical variant of chronic actinic dermatitis (CAD) and describes a persistent photoinduced skin disorder often associated with delayed-type hypersensitivity reactions. Histopathologically, AR resembles pseudolymphoma and may also show features of cutaneous lymphoma. In contrast to other UV-induced skin diseases, AR patients show persistent photosensitivity to UV radiation and visible light parallel to permanent changes of skin texture with infiltrated papules and thick… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 35 publications
(36 reference statements)
0
2
0
1
Order By: Relevance
“…Treatment of CAD is often difficult. However, avoidance of ultraviolet radiation exposure, and the oral administration of steroids are sometimes effective for CAD 6 . In our case, the skin lesion was severe in the dorsal aspect of the hand, although no other sun‐exposed regions were affected.…”
mentioning
confidence: 63%
“…Treatment of CAD is often difficult. However, avoidance of ultraviolet radiation exposure, and the oral administration of steroids are sometimes effective for CAD 6 . In our case, the skin lesion was severe in the dorsal aspect of the hand, although no other sun‐exposed regions were affected.…”
mentioning
confidence: 63%
“…En caso de que se identifiquen alérgenos de contacto o de contacto con la luz solar, se deben evitar 59 . Como tratamiento de primera línea se usan los esteroides tópicos de mediana o alta potencia, o inhibidores tópicos de la calcineurina [67][68][69] . Para la enfermedad generalizada o resistente al tratamiento, se usan medicamentos inmunosupresores.…”
Section: Tratamientounclassified
“…There are a few case reports of successful treatments, including resistant lesions of CAD. This beneficial effect may be attributed to the fact that CAD is characterized by a lymphohistiocytic infiltrate producing a chronic eczema and that tacrolimus blocks the activation of lymphocytes and other immune system cells, also inhibiting the release of mediators from cutaneous mast cells and basophils 24 …”
Section: Contact Hypersensitivitymentioning
confidence: 99%